Finance

Lists
Q3 2026 earnings • released • EPS beat +39.30% • Revenue beat +1.00%
See results
SOPH:NASDAQ
Sophia Genetics SA
$6.64
-4.73%
(-0.33) 1D
Nov 5, 3:54:13 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOPH...
Open
$6.71
High
$6.86
Low
$6.39
Mkt. cap
568.77M
Avg. vol.
631.61K
Volume
627.24K
52-wk high
$8.98
52-wk low
$3.83
EPS
-$1.15
Beta
1.09
Shares outstanding
85.13M
No. of employees
415
Open
$6.71
High
$6.86
Low
$6.39
Mkt. cap
568.77M
Avg. vol.
631.61K
Volume
627.24K
52-wk high
$8.98
52-wk low
$3.83
EPS
-$1.15
Beta
1.09
Shares outstanding
85.13M
No. of employees
415
News stories
From web sources and news partners
Profile
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions. Wikipedia
About Sophia Genetics SA
CEOJurgi Camblong
Employees415
FoundedJan 1, 2011
Headquarters-
SectorHealth Care
Industry-
Websitesophiagenetics.com
Analyst ratings
Based on 3 analysts giving stock ratings to SOPH in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SOPH in the last 3 months.
Highest
Current $6.64
$14.00 (+110.84%)
Average
$11.50 (+73.19%)
Lowest
$9.00 (+35.54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$14.00
+110.8%
11/05/2026
Mark Massaro
BTIG
Buy
Reiterated
$9.00
+35.5%
11/03/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/25/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$7.00
+5.4%
08/04/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
08/04/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$7.00
+5.4%
05/06/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
-$0.12 / -$0.20
+39.30%beat
Revenue / Est. (USD)
24.27M / 24.03M
+1.00%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.46M
21.71M
21.69M
23.31M
Cost of goods sold
6.56M
7.02M
6.94M
8.25M
Cost of revenue
6.56M
7.02M
6.94M
8.25M
Research and development expenses
8.07M
8.54M
9.46M
8.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.56M
24.65M
22.57M
26.39M
Operating expense
30.77M
33.24M
32.03M
35.11M
Total operating expenses
37.32M
40.25M
38.97M
43.36M
Operating income
-17.86M
-18.54M
-17.28M
-20.05M
Other non operating income
-607.00K
90.00K
-92.00K
-317.00K
EBT including unusual items
-19.38M
-19.57M
-19.07M
-22.28M
EBT excluding unusual items
-19.38M
-19.60M
-19.07M
-22.28M
Income tax expense
642.00K
-395.00K
253.00K
78.00K
Effective tax rate
-3.31%
2.02%
-1.33%
-0.35%
Other operating expenses
143.00K
45.00K
-
-5.00K
Net income
-20.02M
-19.18M
-19.32M
-22.36M
Net profit margin
-102.87%
-88.35%
-89.09%
-95.91%
Earnings per share
-0.20
-0.17
-0.19
-0.20
Interest and investment income
622.00K
381.00K
289.00K
231.00K
Interest expense
-1.66M
-1.67M
-1.67M
-1.62M
Net interest expenses
-1.04M
-1.29M
-1.38M
-1.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.77M
-18.10M
-16.13M
-18.90M
Gain or loss from assets sale
-
-
3.00K
-3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps